Stage I Nsclc clinical trials

Explore recruiting stage i nsclc clinical trials.

Recruiting stage i nsclc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stage I Nsclc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Placebo-Controlled Study of Adjuvant Intismeran Autogene Plus Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) or Intismeran Autogene Monotherapy Versus Placebo in Participants With Completely Resected High-Risk Stage I Non-Small Cell Lung Cancer (INTerpath-014)

Greece, Poland, Italy, Hungary, Germany, Netherlands +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stage I Nsclc trials by city

Stage I Nsclc in Toronto Stage I Nsclc in Vancouver Stage I Nsclc in Montreal Stage I Nsclc in Calgary Stage I Nsclc in Edmonton Stage I Nsclc in Ottawa Stage I Nsclc in Winnipeg Stage I Nsclc in Quebec City Stage I Nsclc in Hamilton Stage I Nsclc in Kitchener Stage I Nsclc in London Stage I Nsclc in Halifax Stage I Nsclc in New York Stage I Nsclc in Los Angeles Stage I Nsclc in Chicago Stage I Nsclc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease